Eagle Bay Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Eagle Bay Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-326	Closed	-$170K	–	872
2024 Q4	$170K	Sell	326 -117	-26%	-$64.3K	0.11%	130
2024 Q3	$274K	Sell	443 -11	-2%	-$6.51K	0.1%	139
2024 Q2	$251K	Sell	454 -207	-31%	-$119K	0.15%	100
2024 Q1	$384K	Sell	661 -83	-11%	-$46.6K	0.24%	72
2023 Q4	$395K	Sell	744 -7	-0.9%	-$3.39K	0.25%	71
2023 Q3	$380K	Buy	751 +295	+65%	+$157K	0.18%	85
2023 Q2	$238K	Sell	456 -334	-42%	-$180K	0.14%	104
2023 Q1	$455K	Sell	790 -215	-21%	-$121K	0.25%	64
2022 Q4	$553K	Buy	1,005 +216	+27%	+$114K	0.31%	57
2022 Q3	$401K	Buy	789 +9	+1%	+$5.04K	0.25%	69
2022 Q2	$424K	Buy	780 +768	+6,400%	+$423K	0.26%	61
2022 Q1	$6K	Sell	12 -433	-97%	-$249K	﹤0.01%	262
2021 Q4	$297K	Sell	445 -69	-13%	-$43.1K	0.19%	78
2021 Q3	$293K	Buy	514 +326	+173%	+$179K	0.16%	91
2021 Q2	$97K	Buy	+188	New	+$88.7K	0.08%	159

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Eagle Bay Advisors's TMO Position: Q1 2025 in Review

Eagle Bay Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 326 shares — an estimated $170K sold.

Eagle Bay Advisors first reported a position in TMO in Q2 2021 and held it in 15 quarters. The position peaked at $553K in Q4 2022. 2,577 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

Eagle Bay Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
Eagle Bay Advisors sold 326 Thermo Fisher Scientific shares in Q1 2025, an estimated $170K.
Eagle Bay Advisors first reported a position in Thermo Fisher Scientific in Q2 2021 and held it in 15 quarters.
Eagle Bay Advisors's Thermo Fisher Scientific position peaked at $553K in Q4 2022.
2,577 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.